Literature DB >> 19800163

Human Wharton's jelly cells can be induced to differentiate into growth factor-secreting oligodendrocyte progenitor-like cells.

Hong-Tian Zhang1, Juan Fan, Ying-Qian Cai, Shu-Ju Zhao, Shan Xue, Jian-Hao Lin, Xiao-Dan Jiang, Ru-Xiang Xu.   

Abstract

Human Wharton's jelly-derived mesenchymal stromal cells (hWJ-MSCs) are capable of differentiating into neural and astroglia-like cell types. However, a reliable means of inducing the selective differentiation of hWJ-MSCs into oligodendrocyte progenitor cells (OPCs) in vitro has not yet been established. In this study, the OPC-like differentiation of hWJ-MSCs was characterized using and immunoblotting. The hWJ-MSC-derived OPC-like cells were able to secrete nerve growth factors and promote neurite outgrowth in vitro. These results show that hWJ-MSCs can be induced to differentiate into cells with the morphologic, phenotypic and functional characteristics of OPC-like cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800163     DOI: 10.1016/j.diff.2009.09.002

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  21 in total

Review 1.  Umbilical cord-derived mesenchymal stem cells: strategies, challenges, and potential for cutaneous regeneration.

Authors:  Siming Yang; Sha Huang; Changjiang Feng; Xiaobing Fu
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

Review 2.  The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine.

Authors:  N Forraz; C P McGuckin
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

3.  Stem cells for reprogramming: could hUMSCs be a better choice?

Authors:  Paulina Duya; Yuhong Bian; Xiaoqian Chu; Yanjun Zhang
Journal:  Cytotechnology       Date:  2012-09-12       Impact factor: 2.058

4.  Stem cells from umbilical cord Wharton's jelly from preterm birth have neuroglial differentiation potential.

Authors:  Marianne Messerli; Anna Wagner; Ruth Sager; Martin Mueller; Marc Baumann; Daniel V Surbek; Andreina Schoeberlein
Journal:  Reprod Sci       Date:  2013-05-13       Impact factor: 3.060

Review 5.  Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility.

Authors:  Tokiko Nagamura-Inoue; Haiping He
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

6.  Neural differentiation of human umbilical cord matrix-derived mesenchymal cells under special culture conditions.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Abdul Manaf Ali; Abdul Rahman Omar; Mojgan Moshrefi; Batool Motamedi; Seyed Noureddin Nematollahi-Mahani
Journal:  Cytotechnology       Date:  2014-10-26       Impact factor: 2.058

7.  In vitro and in vivo magnetic resonance tracking of Sinerem-labeled human umbilical mesenchymal stromal cell-derived Schwann cells.

Authors:  Qiang Xu; Hong-Tian Zhang; Ke Liu; Jun-Hua Rao; Xiao-Ming Liu; Li Wu; Bai-Nan Xu
Journal:  Cell Mol Neurobiol       Date:  2010-12-01       Impact factor: 5.046

Review 8.  Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation?

Authors:  Andres Hilfiker; Cornelia Kasper; Ralf Hass; Axel Haverich
Journal:  Langenbecks Arch Surg       Date:  2011-03-04       Impact factor: 3.445

9.  Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPβ fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications.

Authors:  Viviana Soto-Mercado; Miguel Mendivil-Perez; Carlos Velez-Pardo; Francisco Lopera; Marlene Jimenez-Del-Rio
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

10.  Differentiation of human endometrial stromal cells into oligodendrocyte progenitor cells (OPCs).

Authors:  Somayeh Ebrahimi-Barough; Homa Mohseni Kouchesfahani; Jafar Ai; Mohammad Massumi
Journal:  J Mol Neurosci       Date:  2013-01-22       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.